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Objective
Reduction of b-cell mass is increasingly recognized as
one of the main contributing factors to the pathogenesis
of type 2 diabetes. Chronic free fatty acid (FFA) expo-
sure has been shown to induce endoplasmic reticulum
(ER) stress that may contribute to promoting pancreatic
b-cell apoptosis. In the present study, we first investi-
gated whether anticonvulsant sodium valproate (VPA),
at clinically relevant doses, protects pancreatic b-cell
from palmitate-induced apoptosis and the mechanism
underlying anti-apoptosis.
Methods and results
INS1 cells exposed to 0.25~1.0 mM palmitate for 24~48 h
under serum-free conditions showed marked apoptosis in
time- and concentration-dependent as assessed by CCK-8
assay, Hoechst 33342/PI, flow cytometric cell apoptosis
assay and electron microscopy. Palmitate triggered ER
stress and apoptosis in INS1 cells as evidenced by
increased mRNA levels of C/EBP homologous transcrip-
tion factor (CHOP), activating transcription factor
4 (ATF4) and X box-binding protein 1 (XBP-1) in a time-
dependent fashion. Western blot analysis also showed sig-
nificant increase of CHOP and caspase-3 in protein level.
We also found that palmitate activated GSK3b by inhibit-
ing phosphorylation at serine 9. While chronic, not acute,
1~2 mM VPA and 2 mM LiCl remarkable reduced palmi-
tate-induced cytotoxicity. Furthermore, INS1 cells treated
with 10~20 μM TDZD-8, a specific GSK3b inhibitor, also
elicited cytoprotective responses against 0.25~0.5 mM pal-
mitate for 6~48 h and decreased mRNA level of CHOP,
but not ATF4 or XBP-1. The protein levels of CHOP,
caspase-3 and GSK3b activity were remarkable reduced by
co-treatment of INS1 cells with 0.25mM palmitate and 1
mM VPA, compared with 0.25mM palmitate only. Finally,
down-regulation of CHOP expression in INS1 cells by
small interfering RNA (SiRNA) did not show apparent
cytoprotective responses against 0.25mM palmitate.
Conclusion
ER stress and GSK3b involved in palmitate-induced b-cell
apoptosis, however, GSK3b other than ER stress is likely
playing a more prominent role. Valproate protected pan-
creatic b-cell from palmitate-induced apoptosis and ER
stress by inhibiting GSK3b.
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